Chinese biotech company Adagene raises $50m in new funding round

This article was originally published here

Adagene, an antibody discovery and development company, has raised $50m in Series C financing, led by Sequoia China, and backed by New World TMT, AVIC Trust, King Star Capital, Gopher Asset Management and other investors.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply